Malawi: Our Impact

Management Sciences for Health is pleased to announce publication of the "Evaluation of Malawi's Emergency Human Resource Programme."  The report documents the results of six years of efforts by the Government of Malawi and its partners, Britain's Department for International Development (DFID), and the Global Fund to Fight AIDS, Malaria and Tuberculosis, to overcome its human resources in health crisis.The Emergency Human Resource Programme (EHRP) was launched in 2004 to address this crisis, largely caused by an acute shortage of professional workers in the public health sector.  In

As a partner in the Knowledge for Health project (K4Health), MSH is leading the implementation of a one-year knowledge management “demonstration” project in Nkhotakota and Salima districts in Malawi. The project aims to improve the exchange and use of family planning/reproductive health (FP/RH) and HIV & AIDS knowledge among managers and service providers at the national, district, and community levels to improve FP/RH and HIV & AIDS services. Eighty-three percent of Malawi’s population lives in rural areas.

As a leader in Malawi’s health care sector since 2003, with a strong staff of Malawi managerial and clinical professionals, MSH has worked closely with the Malawi's Ministry of Health (MOH)  to scale up and improve health care service delivery at all levels, while strengthening critical management gaps in Malawi’s health care system.

In Malawi where a district hospital can be many miles from a village, rural communities and health centers are playing a vital role in preventing the spread of tuberculosis (TB) in the country. Working with Malawi CAP’s National Tuberculosis Programme, MSH and the Tuberculosis Control Assistance Program (TB) are training community volunteers and strengthening health centers to improve the TB case detection rate and support HIV and TB diagnosis and treatment services.

In 2006, the Malawi Ministry of Health chose the artemisinin-based combination therapy artemether-lumefantrine as the first-line drug for treating uncomplicated malaria. However, when Malawi officially launched the policy nationwide, one of the greatest challenges was a lack of capacity among health workers and pharmacy personnel to manage the new treatment.

Twenty MSH experts on tuberculosis (TB) from 15 countries showcased the latest global experience and methodologies at the 40th Union Conference on Lung Health, held December 3-7 2009, in Cancun, Mexico.

On October 1, 2009, USAID officially handed over the keys to the newly refurbished and upgraded Central Reference Laboratory (CRL) in Lilongwe, Malawi, to the Ministry of Health in a ceremony attended by representatives from USAID, the Government of Malawi, MSH, the Tuberculosis Control Assistance Program (TB CAP), and other collaborating partners. With the improvements, the CRL is now the first Biosafety Level 3 laboratory based on World Health Organization (WHO) guidelines in Malawi and one of the few laboratories of this level in southern Africa.  According to USAID Charge d&rsquo

MSH: What is your role at MSH? I am the Prevention of Mother-to-Child Transmission (PMTCT) Technical Advisor placed at the Ministry of Health (MOH) in Malawi.MSH: What is the situation in Malawi with respect to the AIDS epidemic? What are Malawi’s greatest challenges in tackling HIV & AIDS? Malawi is experiencing a severe epidemic. Since 1985, when the first AIDS case was diagnosed, HIV prevalence has increased significantly in the 15–49 age group. It rose to 16.2 percent in 1999, before coming down and stabilizing at around 12 percent in 2005.

As we approach World Population Day—which was first observed 22 years ago, on July 11, 1988—many women in the poorest countries, particularly in sub-Saharan Africa, still lack access to modern family planning (FP). As a result, these women suffer high maternal mortality, and their infants die at disproportionately high rates. MSH and its partners are leading a response by developing integrated, community-based FP/HIV services in these countries and repositioning FP as a core activity on the global health agenda.

It has been over six decades since tuberculosis (TB) was deemed a treatable and curable disease. Yet it still remains one of the leading causes of death across the world, killing more than 1.5 million people per year. Despite myths about its danger, misinformation about its breadth, and ignorance about its true burden on the world’s population, TB remains one of the deadliest epidemics in the world. From low detection rates to drug-resistant strains to the continued threat of co-infection with HIV, we need to recognize just how important this fight is.


Printer Friendly Version